Clinical Trial Update: A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Jinling Hospital in China is investigating multimodal radiotherapy for renal cell carcinoma that progressed after prior immunother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Jinling Hospital, China | Conditions: Renal Cell Carcinoma, Radiotherapy | Phase 2 | Status: RECRUITING